---
title: "301096.SZ (301096.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301096.SZ/news.md"
symbol: "301096.SZ"
name: "301096.SZ"
parent: "https://longbridge.com/en/quote/301096.SZ.md"
datetime: "2026-05-21T02:51:53.906Z"
locales:
  - [en](https://longbridge.com/en/quote/301096.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301096.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301096.SZ/news.md)
---

# 301096.SZ (301096.SZ) — Related News

### [Bio-S: The company has not yet laid out processes such as continuous flow hydrogenation and electrocatalysis](https://longbridge.com/en/news/285899593.md)
*2026-05-11T07:37:28.000Z*
> On May 11th, Bio-S stated on the interactive platform that the company has not yet laid out plans for continuous flow hy

### [](https://longbridge.com/en/news/278975346.md)
*2026-03-13T02:55:23.000Z*
> A-share innovative drug concept stocks rose, with Cosunter up over 13%, Staidson BioPharm, ApicHope, Sinocelltech, ALK, 

### [Four companies collectively accepted hearings, and the regulation of the entire chain in the pharmaceutical field is gaining momentum again](https://longbridge.com/en/news/277021631.md)
*2026-02-26T10:09:12.000Z*
> The State Administration for Market Regulation will hold hearings on February 28 for four pharmaceutical companies, incl

### [Bio-S: Wholly-owned subsidiary Methoclopramide Tablets is the first in the country to be approved](https://longbridge.com/en/news/275255368.md)
*2026-02-09T02:34:36.000Z*
> According to Bio-S news, the company's wholly-owned subsidiary, Saimo Pharmaceutical, has become the first in the countr

### [The World Equine Veterinary Association Conference is here! Gongxin-KY's new equine tumor drug clinical data shines](https://longbridge.com/en/news/273803064.md)
*2026-01-27T07:19:11.000Z*
> Gongxin Pharmaceutical released clinical data for its new drug p-TLS at the 2026 World Veterinary Association Conference

### [Announcement from the listed company on December 14, 2025](https://longbridge.com/en/news/269622085.md)
*2025-12-14T09:46:01.000Z*
> On December 14, 2025, Bio-S, SUPLET, MEMSensing, CFT, and other companies announced plans for shareholders and executive

### [Bio-S: Employee strategic placement asset management plan intends to reduce holdings by no more than 550,600 shares](https://longbridge.com/en/news/269619415.md)
*2025-12-14T08:36:06.000Z*
> Bio-S announced that its shareholder Fucheng Haifu Asset Management plans to reduce its holdings by no more than 550,600

### [The "Hidden Relationship" Behind Bio-S's 300 Million Yuan BD Transaction](https://longbridge.com/en/news/267886760.md)
*2025-11-28T19:51:05.000Z*
> Bio-S has reached a BD transaction worth 300 million yuan with Zhongshen Innovation, involving exclusive licensing coope